NationalOmicron And Its Sub-lineage XBB Continue To Be Most Dominant Covid-19 Variant In India: INSACOGBY PTI
InternationalCanada, Australia Impose Covid Restrictions On Travellers From China, Health Experts Doubt The StrategyBY Outlook Web Desk
NationalCovaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows StudyBY Outlook Web Desk
NationalSpike In Covid-19 Cases: The Many Facts And Answers To What's Happening Around CoronavirusBY Outlook Web Desk
InternationalFresh Covid Wave In US? New Omicron Sub-Variants Spark Fears, Read All About ThemBY Outlook Web Desk
BusinessOmicron Threat: Time To Create An Emergency Fund If You Don’t Have One AlreadyBY Outlook Web Desk
NationalOmicron: New Strain Of Coronavirus Escalates Need For Global Vaccine SharingBY Outlook Web Desk
Making A DifferenceCovid Update: Japan Extends Virus Emergency Until End Of SeptemberBY Associated Press
NationalCovid: Over 70 Crore Vaccine Doses Administered In India So Far, Says GovtBY Outlook Web Bureau
NationalIncreased Infectivity, Ability To Escape Immunity: Here’s What Drove Delta VariantBY Outlook Web Bureau
Making A DifferenceCovid Update: Travellers Arriving In Hong Kong From China Will No Longer Need To QuarantineBY Associated Press
NationalIndia May See A Third Covid Wave In October; Intensity Expected To Be 1/4 Of Second Wave: ExpertBY Outlook Web Bureau
Making A DifferenceIs New Covid Variant C.1.2 More Infectious? Here’s What The Study SaysBY Outlook Web Bureau
NationalKerala Covid: Onam Spike Anticipated, Likely To Stay For A Few More Weeks, Say ExpertsBY Preetha Nair
